Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Cancer Res Clin Oncol ; 131(9): 575-80, 2005 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15895252

RESUMEN

PURPOSE: Isolated pelvic perfusion (IPP) therapy exposes target tissues to high doses of anticancer drugs with low systemic concentrations, but the major drawback is drug leakage into the systemic circulation, which often thwarts the increased drug concentration. In this study, the efficacy of altering the in-out flow rate during IPP in order to decrease the leakage was assessed in adult pigs. METHODS: The abdominal aorta and the infrarenal vena cava were occluded with two balloon catheters, blood in the extracorporeal circuit was circulated with twin rotary pumps, and the IPP was performed with platinum. Three sets of in-out flow rates were used, and the degree of drug leakage into the systemic circulation was evaluated. The volume of blood withdrawn was equal to the volume returned (300 ml/min; group A), 5% higher (group B), or 10% higher (group C). The platinum concentrations in the pelvic circulation, systemic circulation, and urine were measured and compared. RESULTS: The average and maximum plasma platinum concentrations in the pelvic circulation did not significantly differ among the three groups. The plasma platinum concentrations in the systemic venous circulation of the three groups significantly (P<0.01) decreased as the volume withdrawn during IPP increased. The percentage of platinum eliminated in the urine during IPP was significantly (P<0.01) lower in group B and C than in group A. CONCLUSIONS: Setting the volume withdrawn higher than the volume returned decreased leakage into the systemic circulation under isolated pelvic perfusion.


Asunto(s)
Antineoplásicos/administración & dosificación , Quimioterapia del Cáncer por Perfusión Regional/métodos , Pelvis/irrigación sanguínea , Platino (Metal)/administración & dosificación , Angiografía , Animales , Antineoplásicos/análisis , Antineoplásicos/farmacocinética , Circulación Sanguínea , Masculino , Modelos Biológicos , Platino (Metal)/análisis , Platino (Metal)/farmacocinética , Flujo Sanguíneo Regional , Porcinos
2.
Hepatogastroenterology ; 52(63): 852-6, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15966219

RESUMEN

BACKGROUND/AIMS: Hepatic arterial infusion chemotherapy via an implantable port system has been widely used to treat unresectable liver neoplasms. Complications of the hepatic artery occlusion following reservoir placement, however, makes it impossible to continue the infusion therapy. The purpose of our study was to assess the possibility of transcatheter treatment after the hepatic artery obstruction following reservoir placement. METHODOLOGY: Between April 1999 and May 2002, 14 patients with liver tumors had the complication of hepatic artery obstruction following reservoir placement. We conducted a prospective trial to assess 1) the collateral pathways of feeding artery using angiography, 2) the possibility of transcatheter treatment or 3) re-reservoir placement for liver tumors. RESULTS: 1) Angiography revealed that the main collateral pathway of the feeding artery was the inferior phrenic artery in 7 patients (50%), the dorsal pancreatic artery in 4 patients (29%) and the anastomotic branch of the celiac axis in 1 patient (7%). The main collateral pathway could not be detected in 2 patients (14%). 2) Transcatheter treatment was successfully performed in all patients (100%). 3) Rereservoir placement failed in all cases. CONCLUSIONS: These results suggest that transcatheter treatment may be possible for patients with hepatic artery obstruction.


Asunto(s)
Carcinoma Hepatocelular/cirugía , Catéteres de Permanencia , Arteria Hepática/cirugía , Bombas de Infusión Implantables , Infusiones Intraarteriales/métodos , Neoplasias Hepáticas/secundario , Neoplasias Hepáticas/cirugía , Complicaciones Posoperatorias/cirugía , Adulto , Anciano , Angiografía , Antineoplásicos/administración & dosificación , Carcinoma Hepatocelular/irrigación sanguínea , Circulación Colateral/fisiología , Constricción Patológica/cirugía , Embolización Terapéutica , Femenino , Arteria Hepática/diagnóstico por imagen , Humanos , Neoplasias Hepáticas/irrigación sanguínea , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Reoperación
5.
AJR Am J Roentgenol ; 183(3): 589-95, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15333340

RESUMEN

OBJECTIVE: We sought to evaluate the efficacy and safety of a hybrid treatment for acute massive pulmonary thromboembolism in patients with hemodynamic impairment by combining mechanical fragmentation, local thrombolysis, and clot aspiration. SUBJECTS AND METHODS: Within a period of 35 months, 25 patients with hemodynamic impairment (eight men and 17 women; age range, 35-77 years) were treated with mechanical thrombus fragmentation using a modified rotating pigtail catheter. After embolus fragmentation, all patients received an intrapulmonary injection of recombinant human-tissue plasminogen activator and then underwent manual clot aspiration with a large-lumen percutaneous transluminal coronary angioplasty guide catheter. RESULTS: All the patients survived, and their clinical status improved. Posttreatment angiography showed an improvement in pulmonary perfusion in all patients (mean Miller score before treatment, 22.2; after treatment, 13.6; p < 0.01). Mean pulmonary artery pressure decreased from 32.6 to 23.4 mm Hg (p < 0.01). Mean treatment time was 124.6 min. CONCLUSION: Hybrid treatment with mechanical fragmentation using a rotating pigtail catheter combined with local fibrinolysis and manual clot aspiration resulted in a rapid and safe improvement in the hemodynamic condition of patients with acute massive pulmonary thromboembolism. This hybrid treatment appears to be especially useful in patients at high risk for right ventricular failure and is a minimally invasive alternative to surgical embolectomy.


Asunto(s)
Embolia Pulmonar/terapia , Enfermedad Aguda , Adulto , Anciano , Cateterismo , Terapia Combinada , Diseño de Equipo , Estudios de Factibilidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Succión , Terapia Trombolítica/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA